Cl[C:2]1[C:11]2[C:6](=[CH:7][C:8]([C:12]3[CH:13]=[C:14]([CH:21]=[CH:22][C:23]=3[CH3:24])[C:15]([NH:17][CH:18]3[CH2:20][CH2:19]3)=[O:16])=[CH:9][CH:10]=2)[CH:5]=[N:4][N:3]=1.[Cl:25][C:26]1[C:27]([S:42]([CH3:45])(=[O:44])=[O:43])=[CH:28][C:29]([CH3:41])=[C:30](B2OC(C)(C)C(C)(C)O2)[CH:31]=1>>[Cl:25][C:26]1[C:27]([S:42]([CH3:45])(=[O:43])=[O:44])=[CH:28][C:29]([CH3:41])=[C:30]([C:2]2[C:11]3[C:6](=[CH:7][C:8]([C:12]4[CH:13]=[C:14]([CH:21]=[CH:22][C:23]=4[CH3:24])[C:15]([NH:17][CH:18]4[CH2:19][CH2:20]4)=[O:16])=[CH:9][CH:10]=3)[CH:5]=[N:4][N:3]=2)[CH:31]=1This material was prepared according to the procedure similar to that described in Method A-Example 3a, using 3-(1-chlorophthalazin-6-yl)-N-cyclopropyl-4-methylbenzamide and 2-(5-chloro-2-methyl-4-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. MS (ESI, pos. ion) m/z: 506.9 (M+1).